Lisinopril Price Trend

Lisinopril Prices December 2023

The price of lisinopril in the USA for Q4 2023 reached 319,510 USD/MT in December. Whereas, the price trend for lisinopril in Asia Pacific Q4 2023 reached 289,715 USD/MT in December 2023. Moreover, lisinopril prices reached 338,740 USD/MT in Europe.

Lisinopril Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Lisinopril Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of lisinopril pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot price of lisinopril at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of lisinopril price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing lisinopril price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Lisinopril Market Analysis

The global lisinopril market size reached US$ 226.5 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 330.8 Million, at a projected CAGR of 4.30% during 2023-2032.

• Lisinopril market is fast growing as the fairly widespread incidence of cardiovascular diseases in people around the world. As per the estimates by the Centers for Disease Control and Prevention indicate that nearly half about 48% of American adults have a diagnosis of cardiovascular disease. In turn, medications like Lisinopril, which cells hypertension and heart failure among other conditions, are used for the management of this kind of illness. In the light of that fact that the heart disease is still the leading cause of mortality in the world today, Lisinopril has as a consequence increased both in demand and acceptance by the global health care providers since these stakeholders are currently prioritizing disease prevention and effective treatment strategies to fight the problem of the common health concern.
• The aging demographic puts Lisinopril in front with the highest demand caused by it. For instance, the Census Bureau statistics indicate that all baby boomers will have reached 65 years and above by 2030, marking an intensity in the wave of the age-related cardiovascular diseases, which entails about 50% individual taking Lisinopril for blood pressure management. Over time, it is common for people to develop hypertension and other heart-related health problems as they age placing a high demand for pharmaceutical drugs such as Lisinopril, to keep at bay heart disease and other cardiovascular disorders among the elderly.
• The development of the Lisinopril market is stimulating due to the growing alarming rate of hypertension. As per the data from the National Institutes of Health, 64% of American adults have hypertension, thus pointing out how essential Lisinopril is in controlling blood pressure correctly. With the increase of the number of people adopting a stationary lifestyle and poor diets, physicians use lisinopril as a medicine to bring patients to their normal level where their blood pressure remains healthy and safe to cut down the risk of cardio-events, increase survival and improve overall health outcomes.

Lisinopril News

The report covers the latest developments, updates, and trends impacting the global lisinopril market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in lisinopril production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the lisinopril price trend.

Latest developments in the lisinopril industry:

• August 2020: Lupin Pharmaceuticals and Sun Pharmaceuticals recalled Lisinopril and Clonazepam tablets for the US market separately. The recall of Lupin's Lisinopril, a widely used drug for hypertension treatment, was caused by the presence of a probable carcinogen in the drug at the above-acceptable levels. The recalls bring to the fore the integral quality control mechanisms of the pharmaceutical industry to ensure reliable and effective medicines for consumers.
• June 2020: the Unichem and Lupin announced the recall of appropriate hypertensive drugs in the American market. Unichem recalled some batches due to the presence of N-nitrosodiethylamine (NDEA), a below-acceptable limit impurity, in combination with tablets of Amlodipine and Hydrochlorothiazide. Also, Lupin has issued a recall for a specific lot of Lisinopril tablets produced to treat high blood pressure. This may have got mixed up with nitrosamine impurity named, N-nitrosodiethylamine (NDEA) in the mixture. The recalls presented also serve as an indication of the ongoing effort by the industry to promote the use of quality and safe medicines in the citizenry and the invariability of the quality control measures to safeguard public health.

Product Description

Lisinopril is a medicine that is prescribed for angiotensin-converting enzyme (ACE) inhibitors. The most common indication is the use of angiotensin receptor blockers (ARBs) for the treatment of hypertension (high blood pressure), congestive heart failure, and cardiac recovery after a myocardial infarction. Lisinopril acts by producing a non-throbbing effect in blood vessels, which consequently decreases blood pressure and facilitates better circulation of blood, relieving the burden on the heart.

Furthermore, Lisinopril is often used to treat additional health problems such as diabetic nephropathy, prevention of stroke as well as certain types of heart diseases. In such instances, it is usually co-administered with other drugs to enhance blood pressure control or to manage associated conditions.

Lisinopril is an oral medication and is taken once a day with or without food. The dosage prescribed may change depending on the patient's general condition and level of reaction to the treatment. It is crucial to stick to the dosage guidelines of the health care team and to attend frequent checkups to keep track of your blood pressure and general health.

Regional Coverage

The report provides a detailed analysis of the lisinopril market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the lisinopril price trend. 

Global Lisinopril Price

The report offers a holistic view of the global lisinopril pricing trends in the form of lisinopril price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of lisinopril but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.

The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed lisinopril demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Lisinopril Price

European lisinopril prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.

This analysis can be extended to include detailed lisinopril price information for a comprehensive list of countries.

North America Lisinopril Price

The analysis of lisinopril prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.

Specific lisinopril historical data within the United States and Canada can also be provided.

Middle East and Africa Lisinopril Price

The report explores the lisinopril pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on lisinopril prices for countries can also be provided.

Asia Pacific Lisinopril Price

The lisinopril pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.

This lisinopril price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Lisinopril Price

The analysis of lisinopril prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of lisinopril pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting lisinopril price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The lisinopril price charts ensure our clients remain at the forefront of the industry.